Commonwealth Medical Clinic

Mount Pearl, Newfoundland and Labrador A1N1W7

0 studies enrolling now · 11 studies all time

What they study most

Acute Coronary Syndrome, Arthritis, Rheumatoid, Coronary Artery Disease, Coronary Heart Disease (CHD), Diabetes Mellitus, Type 2, Influenza A, Myocardial Infarction, Obesity, Overweight, Percutaneous Coronary Intervention, Type 2 Diabetes Mellitus, Vulvodynia

Studies at this site

• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed
• A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before — Completed
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2) — Completed
• A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3) — Completed
• A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight — Completed
• Research Study Looking at How Well Semaglutide Works in People Suffering From Obesity and Knee Osteoarthritis — Completed
• A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease — Completed
• A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications — Stopped early
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Safety and Efficacy of Two Vaginal Products Versus Placebo in Patients With Vaginal Discomfort — Completed
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) — Stopped early